Align Technology, Inc. (ALGN)
NASDAQ
Closed
Aug 24, 2026
Day's Range
159.0752 wk Range
122.00Overview - ALGN - Align Technology, Inc.
Key Statistics
Valuation
Enterprise Value
10.56B
P/E (Trailing)
‪28.22‬
P/E (Forward)
‪12.95‬
PEG Ratio
‪-2.31‬
Price / Sales (TTM)
‪2.78‬
Price / Book
‪2.73‬
EV / EBITDA
‪11.61‬
Profitability
Gross Margin
‪71.71%‬
Profit Margin
‪9.99%‬
Operating Margin
‪18.24%‬
Return on Assets
‪7.40%‬
Return on Equity
‪10.15%‬
Ownership
Shares Outstanding
71.24M
Float
66.88M
Short % of Shares Outstanding
‪6.76%‬
Held by Insiders
‪6.13%‬
Held by Institutions
‪105.19%‬
Price stats
Beta
‪1.65‬
50-Day Avg
‪174.72‬
200-Day Avg
‪169.49‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
17 analysts
Average price target
‪$ 208.60‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ALGN - Align Technology, Inc.
Peers - ALGN - Align Technology, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - ALGN - Align Technology, Inc.
About
Align Technology, Inc. is a medical device company specializing in digital orthodontics and restorative dentistry solutions. Its primary business centers on clear aligner therapy through the Invisalign product family, which is used to treat a wide range of malocclusion cases in collaboration with trained dentists and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
